section name header

Footnotes

a Tested in dextrose 5%.

b Tested in sodium chloride 0.9%.

c Test performed using the formulation WITHOUT edetate disodium.

d Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.

e Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

f Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.

g Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

h Tested in both dextrose 5% and sodium chloride 0.9%.

i Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

j Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

k Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

l Salt not specified.

m Test performed using the formulation WITH edetate disodium.

n Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

o Subvisible particulate test methods include light obscuration, flow imaging microscopy, and backgrounded membrane imaging.

p Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

q Intralipid product.

r SMOFlipid product.